Fabio Benedetti Insider Profile
4 Followers
Fabio Benedetti, SVP, Chief Med Off, Oncology at Geron, holds 38.06K shares in Geron (Ticker: GERN), holds 0.00 shares in Onyx Pharma (Ticker: ONXX).
Fabio Benedetti's Trading History
| GERNGeron | Jun 01, 2009 | SVP, Chief Med Off, Oncology | Uninformative Buy | ― | $35.81K | |
| ONXXOnyx Pharma | ― | ― | ― | ― |
You May Also Like
Fabio Benedetti insider profile FAQ
What is the percentage of profitable transactions made by Fabio Benedetti?
The percentage of profitable transactions made by Fabio Benedetti is 33%.
What is the average return per transaction made by Fabio Benedetti?
The average return per transaction made by Fabio Benedetti is -0.70%.
What stocks does Fabio Benedetti hold?
Fabio Benedetti holds: GERN, ONXX stocks.
What was Fabio Benedetti's most profitable transaction?
Fabio Benedetti’s most profitable transaction was an Informative Sell of GERN stock on June 1, 2009. The return on the trade was 16.60%.
What is Fabio Benedetti's role in Geron?
Fabio Benedetti's role in Geron is SVP, Chief Med Off, Oncology.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
